| For: | Stepanova N. Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials. World J Nephrol 2024; 13(4): 98719 [PMID: 39723354 DOI: 10.5527/wjn.v13.i4.98719] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i4/98719.htm |
| Number | Citing Articles |
| 1 |
Li-min Liu, Xiao-fei He, Yu-lu Zhang, Jing-teng Zhou, Hua Miao, Ying-yong Zhao. Gut microbiota and renal fibrosis: novel mechanistic insights and therapeutic potential. Acta Pharmacologica Sinica 2026; 47(8) doi: 10.1038/s41401-026-01801-0
|
| 2 |
Qian Wang, Jie Chen, Huini Chen, Dongning Liang, Hong Zhou, Juanjuan Chen, Yuan Gui, Fang Yao, Yudan Chen, Xi Zeng, Yaxiang Ma, Dong Zhou, Haiyan Fu. Indole-3-propionic acid exacerbates cisplatin-induced chronic kidney disease through the AHR/NF-κB signaling pathway. iScience 2025; 28(12) doi: 10.1016/j.isci.2025.114149
|
| 3 |
Shoujuan Yu, Huimin Niu, Yan Zhang, Ling Yu, Qi Zhang, Xingchen Liu, Yue Sang, Ran Wang, Min Zhang. Characterization of gut microbiota in patients with diabetic kidney disease. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1713005
|
| 4 |
Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai. Fecal microbiota transplantation is a promising therapy for kidney diseases. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1628722
|
| 5 |
Jiahui Li, Lijia Diao, Menglin Li, Fugang Huang, Ke Sun. Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1642377
|
| 6 |
Parham Montazeri, Bijan Rezakhaniha, Hossein Dialameh, Shahryar Sadeghi, Reza Gerami, Farshad Namdari. Application of probiotics consumption in patients with kidney and urinary tract diseases; a systematic review of clinical evidence and mechanistic insights. Journal of Nephropharmacology 2026; 15(2) doi: 10.34172/npj.12886
|
| 7 |
Jing-Yi Zhan, Wen-Ru Wang, Tian Zhan, Jia-Yi Yang, Ying Liang, Ren-Huan Yu, Xin-Hui Wang. Recent advances in the positive role of Clostridium in autoimmune diseases: as a crucial regulator of restoring immune-metabolic equilibrium. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1730351
|
| 8 |
Haiyan Jiang, Xiaoran Wang, Wei Zhou, Zhili Huang, Wen Zhang. Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1661037
|
| 9 |
Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao. Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine 2025; 148 doi: 10.1016/j.phymed.2025.157496
|
| 10 |
Mengqi Wu, Xin Zhou, Saiping Chen, Yuqing Wang, Bin Lu, Aiping Zhang, Yanqin Zhu, Min Huang, Jiarui Wang, Junyi Liu, Fenggui Zhu, Hong Liu, Riyang Lin. The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1606700
|
| 11 |
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018). Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
|
| 12 |
Shin-Yee Chong, Raja Balqis Raja-Razali, Nor Hidayah Ismail, Muhammad Ameer Ushidee-Radzi, Nur Asyiqin Zahia-Azizan, Muthukumaaran Manickam, Danial ‘Aizat Norhisham, Zul Ilham, Anna Reale, Stefania Nazzaro, Daniela Iovanna, Wan Abd Al Qadr Imad Wan-Mohtar, Tiziana Di Renzo. Probiotic Bacteria in Stimulating Human Physiological Responses: Metabolic Function and Overall Health. Foods 2026; 15(12) doi: 10.3390/foods15122079
|
| 13 |
Jin Rong, Yuanhua Dai, Bo Zhang, Yuxi Li, Kexu Chen, Hanfei Li, Tingting Zhao, Shunmei Liu. Diabetic kidney disease and aging: Focus on gut microbiota. Life Sciences 2025; 381 doi: 10.1016/j.lfs.2025.123999
|
| 14 |
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design, Development and Therapy 2025; doi: 10.2147/DDDT.S557114
|
| 15 |
Zhi-Qing Huang, Huai-Yu Li, Yan-Ting Li, Ruo-Xin Zhang, En Zhang, Bao-Lin Su. Effects of probiotic supplementation on diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1760954
|
| 16 |
瑶 姜. Research Progress of Peritoneal
Dialysis-Associated Peritonitis Risk Factors. Advances in Clinical Medicine 2026; 16(03) doi: 10.12677/acm.2026.163910
|
| 17 |
Yanyan Zhang, Mingli Zhang, Shan Liu, Xingrui Li. Gut microbiota biomarkers of chronic kidney disease progression identified by 16S rDNA sequencing and machine learning. Renal Failure 2026; 48(1) doi: 10.1080/0886022X.2026.2667649
|
| 18 |
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chemico-Biological Interactions 2025; 421 doi: 10.1016/j.cbi.2025.111784
|
| 19 |
Meiling Jin, Lijie Ma, Yuqing Yuan, Kaiyi Zhu, Zhaohui Tong, Qianmei Sun. Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease. VIEW 2026; doi: 10.1002/VIW.20260021
|
| 20 |
Chronic Kidney Disease and the Gut Microbiota: An Expanding Confluence in the Development of the Disease. Comprehensive Physiology 2026; 16(3) doi: 10.1002/cph4.70192
|
| 21 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 22 |
Qianwei Wang, Yucheng Han, Liang Pang, Zhicheng Zhou, Lijuan Dai. Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1620247
|
| 23 |
Tiziana Di Renzo, Anna Reale, Stefania Nazzaro, Daniela Iovanna, Daniela Evangelista, Vasuk Gautam, Bruna Guida, Rosa Carrano, Mauro Cataldi. Impact of Probiotics, Prebiotics and Synbiotics Supplementation in Chronic Kidney Disease: A Comprehensive Review of Clinical Trials. Nutrients 2026; 18(8) doi: 10.3390/nu18081176
|
| 24 |
Yachan Gao, Xinxin Pang, Huichao Zhang, Dongdong Li, Jiarui Han, Zhenyi Chen, Xiaoyong Chen, Dongyang Li. Immune-metabolic interactions shape the fibrotic landscape of diabetic kidney disease: emerging mechanisms and therapeutic prospects. Frontiers in Physiology 2026; 16 doi: 10.3389/fphys.2025.1736472
|
| 25 |
O. Yu. Usenko, O. O. Bilyayeva, I. V. Karol. The Use of Vacuum–Aspiration Systems in Combination with Probiotic Antiseptics in the Comprehensive Treatment of Severe Peritonitis. The Ukrainian Journal of Clinical Surgery 2026; 93(2) doi: 10.26779/2786-832X.2026.2.30
|
| 26 |
Gennaro Argentino, Giuseppe Paribello, Andrea Foderini, Federica Marzano, Maria Amicone, Eleonora Riccio, Antonio Pisani, Simona Andriella, Chiara Ruotolo, Tino Paolo Ambrosino, Francesco Cascone, Luigi Di Martino, Andrea Camocardi, Raffaele Genualdo, Francesco Maria Romano, Lucio Selvaggi, Francesco Selvaggi, Marcello Dallio, Alessandro Federico, Luca De Nicola, Carlo Garofalo, Silvio Borrelli. Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective Study. Journal of Renal Nutrition 2026; 36(2) doi: 10.1053/j.jrn.2025.10.010
|
| 27 |
Cláudia Silva Souza, Niels Olsen Saraiva Camara, Thaís Alves-Silva. Microbiota management: a perspective for kidney transplant patients. Frontiers in Transplantation 2026; 5 doi: 10.3389/frtra.2026.1703048
|
| 28 |
Ziyi Li, Shi Yang, Xinyi Zhou, Yan Qing, Tiyan Zhang, Wenliu Xu, Wei Duan, Fajian Ren, Hua Deng, Wenjing Wang, Ming Li, Min Feng, Chaolong Rao. Alterations in gut–kidney axis indicators and TMAO-related biomarkers in elderly patients with hypertensive nephropathy. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1671036
|
| 29 |
Maurizio Salvadori, Giuseppina Rosso. Gut-kidney axis: Dysbiosis and renal disease. World Journal of Nephrology 2026; 15(1): 115357 doi: 10.5527/wjn.v15.i1.115357
|